Literature DB >> 31188051

Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.

Marjan Mansourian1,2, Midia Babahajiani3, Tohid Jafari-Koshki4,5, Hamidreza Roohafza6, Masoumeh Sadeghi6, Nizal Sarrafzadegan2,7.   

Abstract

Background: The risk of cardiovascular events in individuals with metabolic syndrome (MetS) is higher than in general populations. We aimed at assessing the association between cardiovascular disease (CVD) and MetS and at identifying triple components that are the most predictive of future CVD events.
Methods: Data on 1387 CVD-free individuals recruited in an ongoing cohort in Isfahan, Iran (ICS) were analyzed. This included serum tests and health and lifestyle questionnaires measured at baseline in 2001, 2007, and 2013. The association between CVD and MetS, irrespective of composing components, was evaluated by using logistic regression. The hazard ratio (HR) of CVD events after MetS diagnosis was calculated for different combinations by using Cox PH regression.
Results: The prevalence of MetS was 34.4% at baseline, 19.5% of which was with diabetes. The prevalence of hypertension (blood pressure [BP]) and hyperglycemia (fasting plasma glucose [FPG]) increased over time. Irrespective of composing components, the odds of developing CVD in MetS individuals was higher than in those who did not develop MetS with adjusted odds ratio = 1.76; 95% confidence intervals (CI) = 1.22-2.55. Among the five most prevalent triple combinations, there was a significant association between CVD incidence and high-density lipoprotein + BP + waist circumference combination only with HR = 1.66; 95% CI = 1.04-2.67.
Conclusion: Some MetS components are more likely to result in CVD. Identifying the most predictive components could help in the timely initiation of proper interventions rather than waiting for all MetS components or symptoms of CVD.

Entities:  

Keywords:  Iran; cardiovascular disease; metabolic syndrome components; risk

Mesh:

Year:  2019        PMID: 31188051     DOI: 10.1089/met.2018.0136

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  4 in total

1.  Feasibility of identifying and describing the burden of early-onset metabolic syndrome in primary care electronic medical record data: a cross-sectional analysis.

Authors:  Jamie J Boisvenue; Carlo U Oliva; Donna P Manca; Jeffrey A Johnson; Roseanne O Yeung
Journal:  CMAJ Open       Date:  2020-11-24

2.  Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications.

Authors:  Vanessa Bullón-Vela; Itziar Abete; Josep A Tur; Jadwiga Konieczna; Dora Romaguera; Xavier Pintó; Emili Corbella; Miguel A Martínez-González; Carmen Sayón-Orea; Estefanía Toledo; Dolores Corella; Manuel Macías-Gonzalez; Francisco J Tinahones; Montserrat Fitó; Ramon Estruch; Emilio Ros; Jordi Salas-Salvadó; Lidia Daimiel; Catalina M Mascaró; Maria Angeles Zulet; José Alfredo Martínez
Journal:  Ther Adv Endocrinol Metab       Date:  2020-10-23       Impact factor: 3.565

3.  Impact of Metabolic Syndrome Components in High-Risk Cardiovascular Disease Development in Older Adults.

Authors:  Yuri Gustavo de Sousa Barbalho; Marina Morato Stival; Luciano Ramos de Lima; Izabel Cristina Rodrigues da Silva; Alessandro de Oliveira Silva; Manoela Vieira Gomes da Costa; Tania Cristina Morais Santa Barbara Rehem; Silvana Schwerz Funghetto
Journal:  Clin Interv Aging       Date:  2020-09-18       Impact factor: 4.458

4.  Prevalence of metabolic syndrome, its risk factors and associated lifestyles in Myanmar adult people: A community based cross-sectional study.

Authors:  Su Su Maw
Journal:  Metabol Open       Date:  2021-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.